Healthtech startup valuations
Where healthtech companies are priced at pre-seed in the US, and at seed and Series A in Europe.
- Data as of Q2 2026
- Updated 20 August 2026
- Sources: Carta and PitchBook
At a glance
- US pre-seed median cap
- $17M
- Healthtech, raising $1M–$2.5M, post-money
- Carta, Q2 2026 · Estimated
- US pre-seed median cap, small rounds
- $10M
- Healthtech, raising under $250k
- Carta, Q2 2026 · Estimated
- Europe, pre-seed and seed
- €4.8M
- Median pre-money, healthtech
- 2025: €4.9M · down about 2% by H1 2026
- PitchBook, H1 2026
- Europe, Series A and B
- €25.9M
- Median pre-money, healthtech
- 2025: €22.7M · up about 14% by H1 2026
- PitchBook, H1 2026
What the numbers say
A US healthtech company raising $1M–$2.5M on a SAFE had a median cap of about $17M, close to the figure for all industries. Rounds of under $250k had a median cap of about $10M.
In Europe, healthtech sat at €4.8M at pre-seed and seed (down about 2% on 2025) and €25.9M at Series A and B (up about 14% on 2025): the lowest Series A and B median of the sectors PitchBook tracks.
The full tables
| Amount raised | 25th percentile | Median | 75th percentile | 90th percentile |
|---|---|---|---|---|
| Under $250k | $6.3M | $10M | $15M | $28M |
| $250k–$500k | $7.2M | $12M | $18M | $30M |
| $500k–$1M | $8.8M | $13M | $25M | $41M |
| $1M–$2.5M | $12M | $17M | $26M | $42M |
| $2.5M and up | $18M | $24M | $41M | $82M |
Post-money valuation caps, by the amount raised on the SAFE. Carta's figures for this industry, moved to Q2 2026's level, so all of them are estimated.
Sources: Carta, State of Pre-Seed: Q2 2026
| Stage | 25th percentile | Median | 75th percentile | 90th percentile |
|---|---|---|---|---|
| Pre-seed and seed | €2.4M | €4.8M | €9.5M | €19M |
| Series A and B | €13M | €25.9M | €63M | €150M |
PitchBook's medians; the 25th, 75th and 90th percentiles are estimated from the spread of its own chart.
Sources: PitchBook, Q2 2026 European VC Valuations Report
- Carta prints SAFE caps by industry for several quarters together. We move them to the level of Q2 2026 by the same factor as all industries, so every US figure here is an estimate.
- PitchBook prints medians, and groups pre-seed with seed and Series A with Series B. We estimate the 25th, 75th and 90th percentiles from the spread of its own chart, scaled to each median.
- The figures for the year before are PitchBook's. Where it prints the change, we show its figure; elsewhere we work it out from the two medians, to the nearest percent.